Position history for MARSHALL WACE, LLP's holdings in TREVI THERAPEUTICS INC
MARSHALL WACE, LLP holds 4.6M shares of TRVI (TREVI THERAPEUTICS INC), worth $57.3M as of 2025-Q4. The position was decreased (-5.4% shares). TRVI represents 0.1% of MARSHALL WACE, LLP's portfolio.
Current Value
$57.3M
Current Shares
4.6M
Total Value Change
+$57.1M
Total Shares Change
+4.5M
Other major holders of TRVI: BlackRock, Inc., FMR LLC, VANGUARD GROUP INC
Decreased |
| 4.6M |
-5.4% |
| $57.3M |
| 0.1% |
| $12.56 |
0 |
| 2025-Q3 | Increased | 4.8M | +95.4% | $44.3M | 0.0% | $8.95 | 47 |
| 2025-Q2 | Decreased | 2.5M | -3.0% | $13.6M | 0.0% | $5.62 | 0 |
| 2025-Q1 | Increased | 2.6M | +5851.0% | $16.1M | 0.0% | $6.50 | 45 |
| 2024-Q4 | Decreased | 42,921 | -47.1% | $176,835 | 0.0% | $4.10 | 0 |
| 2024-Q3 | New | 81,124 | - | $270,954 | 0.0% | $3.33 | 32 |